This funding opportunity supports pilot projects aimed at elucidating the role of understudied proteins associated with rare diseases. It provides funding to generate preliminary data and develop research tools through basic biochemical and biological studies, focusing on druggable protein families linked to rare diseases. Clinical trials are not allowed under this award.
Eligible applicants include a wide range of U.S.-based institutions such as public and private higher education institutions, small businesses, nonprofits, government entities, tribal organizations, and certain minority-serving institutions. Non-U.S. entities are not eligible to apply, though foreig
